Menu
GWAS Study

A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia.

Ferrari R, Grassi M, Salvi E et al.

26154020 PubMed ID
GWAS Study Type
1456 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FR
Ferrari R
GM
Grassi M
SE
Salvi E
BB
Borroni B
PF
Palluzzi F
PD
Pepe D
DF
D'Avila F
PA
Padovani A
AS
Archetti S
RI
Rainero I
RE
Rubino E
PL
Pinessi L
BL
Benussi L
BG
Binetti G
GR
Ghidoni R
GD
Galimberti D
SE
Scarpini E
SM
Serpente M
RG
Rossi G
GG
Giaccone G
TF
Tagliavini F
NB
Nacmias B
PI
Piaceri I
BS
Bagnoli S
BA
Bruni AC
MR
Maletta RG
BL
Bernardi L
PA
Postiglione A
MG
Milan G
FM
Franceschi M
PA
Puca AA
NV
Novelli V
BC
Barlassina C
GN
Glorioso N
MP
Manunta P
SA
Singleton A
CD
Cusi D
HJ
Hardy J
MP
Momeni P
Chapter II

Abstract

Summary of the research findings

Frontotemporal dementia (FTD) is the second most prevalent form of early onset dementia after Alzheimer's disease (AD). We performed a case-control association study in an Italian FTD cohort (n = 530) followed by the novel single nucleotide polymorphisms (SNPs)-to-genes approach and functional annotation analysis. We identified 2 novel potential loci for FTD. Suggestive SNPs reached p-values ∼10(-7) and odds ratio > 2.5 (2p16.3) and 1.5 (17q25.3). Suggestive alleles at 17q25.3 identified a disease-associated haplotype causing decreased expression of -cis genes such as RFNG and AATK involved in neuronal genesis and differentiation and axon outgrowth, respectively. We replicated this locus through the SNPs-to-genes approach. Our functional annotation analysis indicated significant enrichment for functions of the brain (neuronal genesis, differentiation, and maturation), the synapse (neurotransmission and synapse plasticity), and elements of the immune system, the latter supporting our recent international FTD-genome-wide association study. This is the largest genome-wide study in Italian FTD to date. Although our results are not conclusive, we set the basis for future replication studies and identification of susceptible molecular mechanisms involved in FTD pathogenesis.

530 European ancestry cases, 926 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1456
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Italy
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.